NCT06247189Recruiting
ICOPE Program Feasibility in the Management of Myeloma Patients
Onco-ICOPE: ICOPE Program Feasibility in the Management of Myeloma Patients Over 70 Years
Source: ClinicalTrials.gov · Last updated 22 Dec 2025
Brief summary (registry, in English)
This project proposes to adapt monthly the existing ICOPE (Integrated Care for Older People) MONITOR program for elderly myeloma patients. This adaptation aims to detect earlier functional decline and prevent loss of autonomy.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- First submitted
- 30 Jan 2024
- Start date
- Dec 2025
- Primary completion date
- Dec 2026
- Lead sponsor
- University Hospital, Toulouse
- Diseases
- Multiple myeloma
- NCT number
- NCT06247189
What you commit to
- Study type: Interventional
- Planned participants: 30
- From Dec 2025 to the primary completion date, Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Patient in palliative care
- Patient participating in a study evaluating another frailty prevention program
- Patient unable to understand the study
- Patient under court protection, guardianship or curatorship,
- Patient refusal.
Who the study is looking for
- Male or female aged over 70 years,
- Patient with multiple myeloma
- WHO performance status 0-3,
- Patient eligible for first- or second-line treatment
- Patient willing to participate in ICOPE MONITOR program
- Patient or caregiver able to use digital tools of ICOPE MONITOR: application or chatbot (computer or tablet or smartphone)
- Patient with a life expectancy of more than 3 months,
- Patient or caregiver able to understand, read and speak French
- Person affiliated or benefiting from a social security.
- Free, informed and written consent signed by the participant and the investigator (at the latest on the day of inclusion and before any examination required by the research)
Age in the registry: 70 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| CHU de Toulouse Coordinator of this site? Confirm its status | Toulouse | France | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.